COVID-19 Cases Are Rising Again

COVID-19 Cases Are Rising Again

Healthcare, Laboratories and Workplaces Should Be Doing This Now

As the autumn of 2026 arrives and cooler weather draws people indoors, seasonal respiratory infections are following their familiar pattern. According to the UK Health Security Agency (UKHSA) national flu and COVID-19 surveillance report for the week ending 4 October 2026, COVID-19 activity in England has registered an increase across multiple surveillance indicators.

The numbers reflect an active seasonal shift:

Hospital Positivity:

SARS-CoV-2 PCR positivity in hospital testing rose to 9.1%, compared with 7.9% the previous week.

Hospital Admissions:

Weekly COVID-19 hospital admissions climbed to 2.04 per 100,000, up from 1.75 per 100,000, with total confirmed hospital cases reaching 1,638.

Vulnerable Cohorts:

Positivity remained highest among older adults, with positive test rates in people aged 85 and over reaching 13.1%.

Importantly, UKHSA consultant epidemiologists emphasize that COVID-19 is currently circulating at overall low baseline levels. The present rise is neither unexpected nor a reason for alarm. However, after several years of shifting pandemic guidance and waning public caution, this seasonal increase provides an essential, timely hook for healthcare trusts, care providers, diagnostic laboratories, and commercial workplaces to ensure their winter biosecurity plans are functioning properly.

Actions for Acute Healthcare and Adult Social Care

In hospitals, hospices, and residential care homes, the priority is protecting clinically vulnerable individuals and preventing institutional outbreaks that lead to bed blocking and winter staffing crises:

Accelerate Autumn Vaccination Rollout:

Surveillance data indicates that by early October, only 10.2% of people aged 75 and over and 4.1% of immunosuppressed individuals had received their Autumn booster dose. Care homes and community trusts must urgently facilitate on-site vaccination clinics for residents and staff.

Point-of-Care Multiplex Screening:

Symptoms of COVID-19, Influenza A and B, and Respiratory Syncytial Virus (RSV) overlap significantly in frail patients. Clinical teams should avoid guessing diagnoses; deploying multiplex rapid PCR or antigen panels ensures that influenza patients receive antivirals like oseltamivir quickly, while COVID-19 positive patients receive nirmatrelvir/ritonavir (Paxlovid) or remdesivir where indicated.

Calibrated Mask Policies and Isolation:

During periods of rising local community transmission, staff providing direct personal care to high-risk, immunocompromised residents should wear fluid-resistant Type IIR surgical masks. Symptomatic residents should be cared for in single rooms with dedicated sanitary facilities.

Diagnostic and Pathology Laboratories

Medical and microbiology laboratories play a crucial role in national winter surveillance:

Maintain High-Throughput Capacity:

Laboratories contributing to the UKHSA Respiratory DataMart system must ensure robust staffing and reagent pipelines to maintain fast turnaround times as seasonal specimen volumes double between October and January.

Specimen Biosafety:

Diagnostic handling of routine clinical respiratory swabs should proceed strictly under Containment Level 2 (CL2) conditions, ensuring appropriate aerosol containment during centrifugation and vortexing.

Genomic Surveillance and Variant Tracking:

Laboratories must continue routing a defined proportion of positive PCR samples to national sequencing centres to monitor the evolution of circulating spike mutations and recombinant lineages.

Workplaces and Commercial Facilities

For general office environments, schools, retail facilities, and industrial workplaces, the strategy should focus on sustainable, non-disruptive health measures:

Indoor Air Quality and Ventilation:

Because SARS-CoV-2 is an airborne pathogen spread via microscopic respiratory aerosols, indoor air exchange is the most potent environmental countermeasure. Facilities managers should monitor carbon dioxide (CO2) levels, aiming to keep occupied spaces below 800 parts per million (ppm). Where mechanical HVAC systems are installed, ensure filters are clean (upgrading to MERV-13 or HEPA where feasible) and maximize outside air intake rather than recirculating stale indoor air. In naturally ventilated offices, purge rooms by opening windows between meetings.

Normalise Staying at Home When Febrile:

Workplaces must maintain supportive, non-punitive sickness policies. Staff exhibiting high fevers, heavy coughing, or acute respiratory symptoms should be encouraged to work remotely or rest at home until symptoms subside, rather than 'powering through' and seeding office-wide infection chains.

Surface Hygiene Fundamentals:

Because SARS-CoV-2 is an enveloped virus, it is structurally fragile on environmental surfaces. Routine daily cleaning with standard hospital-grade detergents or multi-surface virucides (including 1% Rely+On® Virkon® as a direct spray, or in combination with wipes) is completely sufficient for desks, meeting room tables, and shared touchpoints. Costly whole-room fogging exercises are unnecessary for managing COVID-19 in ordinary workplace settings.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.